NovaBay Pharmaceuticals (NBY) Leases (2019 - 2025)
Historic Leases for NovaBay Pharmaceuticals (NBY) over the last 13 years, with Q3 2025 value amounting to $189000.0.
- NovaBay Pharmaceuticals' Leases fell 8186.18% to $189000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $189000.0, marking a year-over-year decrease of 8186.18%. This contributed to the annual value of $955000.0 for FY2024, which is 2631.17% down from last year.
- As of Q3 2025, NovaBay Pharmaceuticals' Leases stood at $189000.0, which was down 8186.18% from $306000.0 recorded in Q2 2025.
- NovaBay Pharmaceuticals' Leases' 5-year high stood at $2.3 million during Q1 2022, with a 5-year trough of $170000.0 in Q3 2021.
- Moreover, its 5-year median value for Leases was $1.1 million (2024), whereas its average is $1.1 million.
- In the last 5 years, NovaBay Pharmaceuticals' Leases skyrocketed by 103941.18% in 2022 and then crashed by 8186.18% in 2025.
- Quarter analysis of 5 years shows NovaBay Pharmaceuticals' Leases stood at $411000.0 in 2021, then skyrocketed by 345.5% to $1.8 million in 2022, then fell by 29.22% to $1.3 million in 2023, then decreased by 26.31% to $955000.0 in 2024, then plummeted by 80.21% to $189000.0 in 2025.
- Its last three reported values are $189000.0 in Q3 2025, $306000.0 for Q2 2025, and $343000.0 during Q1 2025.